College of Life Science, Fujian Normal University, Fuzhou 350117, China.
Department of Engineering, Aarhus University, Gustav Wieds Vej 10, 8000 Aarhus C, Denmark.
Bioresour Technol. 2017 Aug;238:129-138. doi: 10.1016/j.biortech.2017.04.041. Epub 2017 Apr 12.
Human milk fat substitutes (HMFs) with four kinds of n-3 fatty acid for infant formula were firstly synthesized using triacylglycerols (TAGs) from Nannochloropsis oculata rich in PA at the sn-2 position and free fatty acids (FFAs) from Isochrysis galbana rich in n-3 polyunsaturated fatty acids (n-3 PUFAs-ALA/SDA/DHA) via solvent-free acidolysis with Novozym 435, Lipozyme 435, TL-IM and RM-IM as biocatalysts. The results show that the resulting HMFs contain total n-3 PUFA of 13.92-17.12% and PA of 59.38-68.13% at the sn-2 position under the optimal conditions (mole ratio FFAs/TAG 3:1, 60°C (Novozym 435 and Lipozyme TL-IM) and 50°C (Lipozyme 435 and RM-IM), lipase loading 10%, reaction time 24h). Moreover, among the tested enzymes, Lipozyme 435, TL-IM, and RM-IM display the fatty acid selectivity towards SDA, LA and ALA, and OA, respectively. Overall, the examined lipases are promising biocatalysts for producing high-value microalgal HMFs in a cost-effective manner.
首次使用富含多不饱和脂肪酸(PUFA)的 Nannochloropsis oculata 的三酰基甘油(TAGs)和富含 n-3 多不饱和脂肪酸(n-3 PUFA-ALA/SDA/DHA)的 Isochrysis galbana 的游离脂肪酸(FFAs)作为酰基供体,通过 Novozym 435、Lipozyme 435、TL-IM 和 RM-IM 作为生物催化剂,在无溶剂条件下酸解合成了 4 种 n-3 脂肪酸的人乳脂肪替代品(HMFs)。结果表明,在最佳条件下(FFAs/TAG 摩尔比为 3:1,60°C(Novozym 435 和 Lipozyme TL-IM)和 50°C(Lipozyme 435 和 RM-IM),脂肪酶用量为 10%,反应时间 24h),所得 HMFs 在 sn-2 位含有总 n-3PUFA13.92%-17.12%和 PA59.38%-68.13%。此外,在所测试的酶中,Lipozyme 435、TL-IM 和 RM-IM 对 SDA、LA 和 ALA 以及 OA 分别表现出脂肪酸选择性。总之,所研究的脂肪酶是一种很有前途的生物催化剂,可用于以经济有效的方式生产高附加值的微藻 HMFs。